One-stop cervical cancer screening could save lives of women with HIV in cameroon
NCT ID NCT07177170
First seen Jun 25, 2026 · Last updated Jun 25, 2026
Summary
This study tests whether a single-visit approach to cervical cancer screening and treatment can reduce dropout rates among women living with HIV in Cameroon. About 1,422 women will be offered HPV testing and same-day treatment if needed. Researchers will compare completion rates between the single-visit method and a more flexible, patient-choice approach. The goal is to find a practical way to prevent cervical cancer in resource-limited settings.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for HIV are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
Foumban hospital
RECRUITINGFoumban, Cameroon
Contact Phone: •••-•••-•••• Email: •••••@•••••
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
What this could lead to
If successful, this could show that a single-visit screening and treatment approach is feasible and acceptable, reducing cervical cancer deaths among women with HIV in resource-limited settings.
What could go wrong
This is an early-stage implementation study, not a treatment trial. Results may not apply to other settings, and the approach may not reduce dropout as hoped.
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.